The Ministry of Health has implemented a significant change, lowering the maximum allowable price for a substantial number of medications. Specifically, the action affects 156 original drugs, 174 generic drugs, and 13 imported drugs. This move has been positively received by Sasho Klekovski, the Director of the Health Insurance Fund.
Klekovski believes this adjustment will significantly benefit citizens by allowing them to access necessary medications at a reduced cost. He explained that the maximum price reduction will impact drugs not included on the positive list, and for those on the list, the additional payments will lessen. Typically, reference prices remain lower than the established maximums.
Klekovski further suggested a potential decrease in payments for drugs listed on the positive list, or even the elimination of these payments entirely. When questioned about the differing drug prices observed in neighboring countries, he acknowledged the situation. The Ministry’s decision aims to control the price of these drugs and ensure affordability for the public.
Klekovski’s comments highlight the importance of this intervention in managing medication costs and providing access to essential drugs for all citizens.
Topics: #drugs #price #klekovski
Klekovski announced that citizens will obtain prescriptions at discounted rates.
The Ministry of Health has introduced a notable adjustment, decreasing the highest permitted cost for a large selection of pharmaceuticals. This change specifically impacts 156 branded drugs, 174 gene